Pages that link to "Q41466470"
Jump to navigation
Jump to search
The following pages link to Gene silencing by CRISPR interference in mycobacteria (Q41466470):
Displaying 50 items.
- Emerging Technologies to Create Inducible and Genetically Defined Porcine Cancer Models (Q26765901) (← links)
- Current and future prospects for CRISPR-based tools in bacteria (Q26783837) (← links)
- The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans (Q26785937) (← links)
- The application of tetracyclineregulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis (Q26795478) (← links)
- Quantification of the gene silencing performances of rationally-designed synthetic small RNAs (Q27346857) (← links)
- Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense (Q28551800) (← links)
- Depletion of Undecaprenyl Pyrophosphate Phosphatases Disrupts Cell Envelope Biogenesis in Bacillus subtilis. (Q30819563) (← links)
- Bacterial CRISPR: accomplishments and prospects. (Q34044882) (← links)
- Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference (Q34046112) (← links)
- A Comprehensive, CRISPR-based Functional Analysis of Essential Genes in Bacteria (Q34528722) (← links)
- High-throughput bacterial functional genomics in the sequencing era (Q35763687) (← links)
- CRISPR/Cas9-The ultimate weapon to battle infectious diseases? (Q36196813) (← links)
- Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system. (Q37336948) (← links)
- CRISPR interference (CRISPRi) for gene regulation and succinate production in cyanobacterium S. elongatus PCC 7942. (Q37417157) (← links)
- Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis (Q37497737) (← links)
- Recent Advances in CRISPR-Cas9 Genome Editing Technology for Biological and Biomedical Investigations (Q38679054) (← links)
- Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics (Q38745100) (← links)
- CRISPR-Cas9 technology: applications in genome engineering, development of sequence-specific antimicrobials, and future prospects (Q38775349) (← links)
- Strategies of genome editing in mycobacteria: Achievements and challenges (Q38828644) (← links)
- Characterization of a secretory hydrolase from Mycobacterium tuberculosis sheds critical insight into host lipid utilization by M. tuberculosis (Q40208641) (← links)
- Construction of a Gene Knockdown System Based on Catalytically Inactive ("Dead") Cas9 (dCas9) in Staphylococcus aureus (Q40250220) (← links)
- Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform (Q40343712) (← links)
- Characterization of Engineered PreQ1 Riboswitches for Inducible Gene Regulation in Mycobacteria (Q40378791) (← links)
- CRISPR-Cas12a-Assisted Recombineering in Bacteria (Q41357802) (← links)
- Progress and Prospects of CRISPR/Cas Systems in Insects and Other Arthropods (Q41430829) (← links)
- Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium (Q41487568) (← links)
- Enabling faster Go/No-Go decisions through secondary screens in anti-mycobacterial drug discovery (Q41927049) (← links)
- Development of a CRISPR-Cas9 Tool Kit for Comprehensive Engineering of Bacillus subtilis (Q42093307) (← links)
- Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis (Q42517549) (← links)
- The preprotein translocase YidC controls respiratory metabolism in Mycobacterium tuberculosis (Q42563552) (← links)
- Characterizing a thermostable Cas9 for bacterial genome editing and silencing (Q47095267) (← links)
- Application of CRISPR interference for metabolic engineering of the heterocyst-forming multicellular cyanobacterium Anabaena sp. PCC 7120. (Q47372433) (← links)
- Genome editing technologies to fight infectious diseases (Q47392998) (← links)
- Tailor-made gene silencing of Staphylococcus aureus clinical isolates by CRISPR interference. (Q47555347) (← links)
- RNA-guided single/double gene repressions in Corynebacterium glutamicum using an efficient CRISPR interference and its application to industrial strain (Q48044045) (← links)
- Feasibility of a Conditional Knockout System for Chlamydia Based on CRISPR Interference. (Q52430804) (← links)
- Gene repression via multiplex gRNA strategy in Y. lipolytica. (Q52431748) (← links)
- CRISPR-based genomic tools for the manipulation of genetically intractable microorganisms. (Q52620802) (← links)
- New Insights on Steroid Biotechnology. (Q55129887) (← links)
- Pooled CRISPR interference screening enables genome-scale functional genomics study in bacteria with superior performance. (Q55432305) (← links)
- CRISPR-Cas System: History and Prospects as a Genome Editing Tool in Microorganisms (Q57253687) (← links)
- CRISPR-Cas9/Cas12a biotechnology and application in bacteria (Q57818221) (← links)
- Regulation and overexpression studies of YidC in Mycobacterium tuberculosis (Q59329189) (← links)
- Measuring the Global Substrate Specificity of Mycobacterial Serine Hydrolases Using a Library of Fluorogenic Ester Substrates (Q59918605) (← links)
- Gene silencing based on RNA-guided catalytically inactive Cas9 (dCas9): a new tool for genetic engineering in Leptospira (Q61796697) (← links)
- Editing the microbiome the CRISPR way (Q64056385) (← links)
- Comparative analysis of homologous aminopeptidase PepN from pathogenic and non-pathogenic mycobacteria reveals divergent traits (Q64061104) (← links)
- Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in (Q64117914) (← links)
- A CRISPR Interference Platform for Efficient Genetic Repression in (Q64241491) (← links)
- CRISPR-Cas9 Mediated Genome Editing in Bicyclus anynana Butterflies. (Q64937079) (← links)